193 related articles for article (PubMed ID: 11046009)
1. Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo.
Gorczynski RM; Yu K; Clark D
J Immunol; 2000 Nov; 165(9):4854-60. PubMed ID: 11046009
[TBL] [Abstract][Full Text] [Related]
2. Evidence for persistent expression of OX2 as a necessary component of prolonged renal allograft survival following portal vein immunization.
Gorczynski RM; Chen Z; Kai Y; Lei J
Clin Immunol; 2000 Oct; 97(1):69-78. PubMed ID: 10998319
[TBL] [Abstract][Full Text] [Related]
3. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival.
Gorczynski RM; Cattral MS; Chen Z; Hu J; Lei J; Min WP; Yu G; Ni J
J Immunol; 1999 Aug; 163(3):1654-60. PubMed ID: 10415071
[TBL] [Abstract][Full Text] [Related]
4. Regulation of gene expression of murine MD-1 regulates subsequent T cell activation and cytokine production.
Gorczynski RM; Chen Z; Clark DA; Hu J; Yu G; Li X; Tsang W; Hadidi S
J Immunol; 2000 Aug; 165(4):1925-32. PubMed ID: 10925274
[TBL] [Abstract][Full Text] [Related]
5. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo.
Gorczynski RM; Cohen Z; Leung Y; Chen Z
J Immunol; 1996 Jul; 157(2):574-81. PubMed ID: 8752904
[TBL] [Abstract][Full Text] [Related]
6. A role for persisting antigen, antigen presentation, and ICAM-1 in increased renal graft survival after oral or portal vein donor-specific immunization.
Gorczynski RM; Chen Z; Zeng H; Fu XM
Transplantation; 1998 Aug; 66(3):339-49. PubMed ID: 9721803
[TBL] [Abstract][Full Text] [Related]
7. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
[TBL] [Abstract][Full Text] [Related]
8. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
[TBL] [Abstract][Full Text] [Related]
9. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
10. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes.
Gorczynski RM
Immunol Lett; 1992 Jun; 33(1):67-77. PubMed ID: 1427992
[TBL] [Abstract][Full Text] [Related]
12. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
13. Evidence for an immunoregulatory role of OX2 with its counter ligand (OX2L) in the regulation of transplant rejection, fetal loss, autoimmunity and tumor growth.
Gorczynski RM
Arch Immunol Ther Exp (Warsz); 2001; 49(4):303-9. PubMed ID: 11726033
[TBL] [Abstract][Full Text] [Related]
14. Liver nonparenchymal cells involved in hyporesponsiveness induced by portal vein injection of alloantigen.
Chen Y; McKenna GJ; Ong C; Mui AL; Chung SW
Immunol Lett; 2002 Apr; 81(1):1-11. PubMed ID: 11841840
[TBL] [Abstract][Full Text] [Related]
15. Suppression of allograft rejection by Tim-1-Fc through cross-linking with a novel Tim-1 binding partner on T cells.
Xiao L; Fu ZR; Liu F; Zhang LD; Shi XM; Shen XY; Ni ZJ; Fu H; Li RD; Cao XT; Ding GS; Wang QX
PLoS One; 2011; 6(7):e21697. PubMed ID: 21750723
[TBL] [Abstract][Full Text] [Related]
16. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin.
De Creus A; Abe M; Lau AH; Hackstein H; Raimondi G; Thomson AW
J Immunol; 2005 Feb; 174(4):2037-45. PubMed ID: 15699133
[TBL] [Abstract][Full Text] [Related]
17. MD-1 expression regulates direct and indirect allorecognition.
Hadidi S; Gorczynski RM
Tissue Antigens; 2004 Feb; 63(2):132-41. PubMed ID: 14705984
[TBL] [Abstract][Full Text] [Related]
18. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
[TBL] [Abstract][Full Text] [Related]
19. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
Moodycliffe AM; Maiti S; Ullrich SE
J Immunol; 1999 May; 162(9):5156-63. PubMed ID: 10227987
[TBL] [Abstract][Full Text] [Related]
20. Early preferential stimulation of gamma delta T cells by TNF-alpha.
Lahn M; Kalataradi H; Mittelstadt P; Pflum E; Vollmer M; Cady C; Mukasa A; Vella AT; Ikle D; Harbeck R; O'Brien R; Born W
J Immunol; 1998 Jun; 160(11):5221-30. PubMed ID: 9605117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
